Detalhe da pesquisa
1.
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects.
J Infect Chemother
; 30(3): 271-275, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944697
2.
Persistent COVID-19 in immunocompromised patients-Israeli society of infectious diseases consensus statement on diagnosis and management.
Clin Microbiol Infect
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642895
3.
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series.
Med
; 4(9): 600-611.e4, 2023 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562400
4.
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay.
Breast Cancer (Dove Med Press)
; 13: 617-624, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815711
5.
Antibiotic Use during the COVID-19 Pandemic in a Tertiary Hospital with an Ongoing Antibiotic Stewardship Program.
Antibiotics (Basel)
; 10(9)2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572638
6.
Unraveling a Nosocomial Outbreak of COVID-19: The Role of Whole-Genome Sequence Analysis.
Open Forum Infect Dis
; 8(10): ofab120, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631912